At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 23 enrolled
Drug / intervention
Omeprazoledrug
Likely dose
Omeprazole 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Does Omeprazole Decrease Intestinal Calcium Absorption?
In Brief
A Phase 4 clinical trial evaluating Omeprazole for Osteoporosis and 3 related conditions. Completed, enrolled 23 participants across 1 site.
Detailed Summary
The purpose of this study is to measure the effect of omeprazole on intestinal calcium absorption in postmenopausal women.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoporosis, Achlorhydria, GERD, Hip Fracture
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 2007
Enrollment StartJan 2008
Primary CompletionDec 2008
Study CompletionDec 2010
TodayJul 2026
First PostedDec 28, 2007
Enrollment StartJan 1, 2008
Primary CompletionDec 1, 2008
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 18.5 years ago
Interventions
Omeprazoledrug
40 mg po qAM one-half hour before breakfast for 30 days